Cargando…
Enabling technologies driving drug research and development
One of the strategic goals of the European Medicines Agency (EMA) and the European Medicines Regulatory Network is to support the research and uptake of innovative methods and technologies in the development of medicines. To promote this goal, EMA drew up a list of enabling technologies (ETs), which...
Autores principales: | Vass, Panna, Akdag, Dara Sevkan, Broholm, Gabriel Enemark, Kjaer, Jesper, Humphreys, Anthony J., Ehmann, Falk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033683/ https://www.ncbi.nlm.nih.gov/pubmed/36968842 http://dx.doi.org/10.3389/fmed.2023.1122405 |
Ejemplares similares
-
Biomarkers in Medicines Development—From Discovery to Regulatory Qualification and Beyond
por: Hendrikse, Natalie M., et al.
Publicado: (2022) -
Technology Considerations for Enabling eSource in Clinical Research: Industry Perspective
por: Jennings, Donald G., et al.
Publicado: (2020) -
Biomarker and Companion Diagnostics—A Review of Medicinal Products Approved by the European Medicines Agency
por: Orellana García, Laura Patricia, et al.
Publicado: (2021) -
Sulfobutylether-beta-cyclodextrin-enabled antiviral remdesivir: Characterization of electrospun- and lyophilized formulations
por: Szente, Lajos, et al.
Publicado: (2021) -
Digital Technologies and Data Science as Health Enablers: An Outline of Appealing Promises and Compelling Ethical, Legal, and Social Challenges
por: Cordeiro, João V.
Publicado: (2021)